VHL is a rare genetic disease which puts patients at risk of developing benign blood vessel tumours and several cancers More: Welireg approved in US for rare VHL-associated cancers Source: News
read moreMerck’s Welireg scores FDA nod in cancers spurred by rare disease—and its label is broader than expected nhigginsdunn Fri, 08/13/2021 – 15:21 More: Merck's Welireg scores FDA nod in cancers spurred by rare disease—and its label is broader than expected
read moreOgilvy Health’s new PR practice chief talks pharma image and social trends bbulik Fri, 08/13/2021 – 11:43 More: Ogilvy Health's new PR practice chief talks pharma image and social trends Source: fierce
read moreOrganon shares jump as Merck’s new women’s health spinoff posts strong start for biosims, infertility drugs nhigginsdunn Fri, 08/13/2021 – 11:34 More: Organon shares jump as Merck's new women's health spinoff posts strong start for biosims, infertility drugs Source: fierce
read moreJazz’s Xywav scores the first FDA nod in idiopathic hypersomnia, and big sales could follow kdunleavy Fri, 08/13/2021 – 11:15 More: Jazz's Xywav scores the first FDA nod in idiopathic hypersomnia, and big sales could follow Source: fierce
read moreFDA denies Rigel’s COVID-19 hopeful Tavalisse for hospitalized patients, asks for late-stage data aliu Fri, 08/13/2021 – 10:01 More: FDA denies Rigel's COVID-19 hopeful Tavalisse for hospitalized patients, asks for late-stage data Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals